Rene Drucker-Colin
Overview
Explore the profile of Rene Drucker-Colin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramirez-Lopez F, Garcia-Montes J, Millan-Aldaco D, Palomero-Rivero M, Tunez-Finana I, Drucker-Colin R, et al.
Brain Sci
. 2025 Jan;
14(12.
PMID: 39766413
Background/objectives: Dopamine replacement therapy for Parkinson's disease (PD) may lead to disabling incontrollable movements known as L-DOPA-induced dyskinesias. Transcranial magnetic stimulation (TMS) has been applied as non-invasive therapy to ameliorate...
2.
Equihua-Benitez A, Equihua-Benitez J, Guzman-Vasquez K, Prospero-Garcia O, Drucker-Colin R
Brain Res
. 2020 Jun;
1745:146951.
PMID: 32531224
Narcolepsy is a sleep disorder that has been associated with the loss of orexinergic neurons from the lateral hypothalamic area. This loss leads to dysregulated sleep and cataplexy attacks. Therapeutic...
3.
Valencia-Sanchez S, Nava-Castro K, Palacios-Arreola M, Prospero-Garcia O, Morales-Montor J, Drucker-Colin R
PLoS One
. 2019 Nov;
14(11):e0220542.
PMID: 31738771
The impact of performing exercise on the immune system presents contrasting effects on health when performed at different intensities. In addition, the consequences of performing chronic exercise have not been...
4.
Murillo-Rodriguez E, Millan-Aldaco D, Palomero-Rivero M, Morales-Lara D, Mechoulam R, Drucker-Colin R
CNS Neurol Disord Drug Targets
. 2019 Oct;
18(9):705-712.
PMID: 31642794
Background: Excessive daytime sleepiness and cataplexy are among the symptoms of narcolepsy, a sleep disorder caused by the loss of hypocretin/orexin (HCRT/OX) neurons placed into the Hypothalamus (LH). Several treatments...
5.
Collazo-Navarrete O, Hernandez-Garcia D, Guerrero-Flores G, Drucker-Colin R, Guerra-Crespo M, Covarrubias L
Stem Cells Dev
. 2019 May;
28(16):1104-1115.
PMID: 31140356
Transplantation of dopaminergic (DA) cells into the striatum can rescue from dopamine deficiency in a Parkinson's disease condition, but this is not a suitable procedure for regaining the full control...
6.
Garcia-Montes J, Solis O, Enriquez-Traba J, Ruiz-DeDiego I, Drucker-Colin R, Moratalla R
Mol Neurobiol
. 2018 Sep;
56(6):4037-4050.
PMID: 30259400
L-DOPA is the main pharmacological therapy for Parkinson's disease. However, long-term exposure to L-DOPA induces involuntary movements termed dyskinesia. Clinical trials show that dyskinesia is attenuated by metabotropic glutamate receptor...
7.
de-la-Cruz M, Millan-Aldaco D, Soriano-Nava D, Drucker-Colin R, Murillo-Rodriguez E
Brain Res
. 2018 Sep;
1700:181-189.
PMID: 30201258
Background: Obesity is the result of the interaction of multiple variables, including the excessive increase of sugar-sweetened beverages consumption. Diets aimed to treat obesity have suggested the use of artificial...
8.
Medina-Fernandez F, Escribano B, Padilla-Del-Campo C, Drucker-Colin R, Pascual-Leone A, Tunez I
Free Radic Res
. 2018 Feb;
52(4):381-389.
PMID: 29385851
In the last decades, different transcranial magnetic stimulation protocols have been developed as a therapeutic tool against neurodegenerative and psychiatric diseases, although the biochemical, molecular and cellular mechanisms underlying these...
9.
Medina-Fernandez F, Escribano B, Luque E, Caballero-Villarraso J, Gomez-Chaparro J, Feijoo M, et al.
Brain Res Bull
. 2017 Dec;
137:140-145.
PMID: 29198860
The effects of transcranial magnetic stimulation (TMS), natalizumab (nata), dimethyl fumarate (DMF) and dexamethasone (DEX) on clinical score and oxidative stress produced by a single dose of myelin oligodendrocyte glycoprotein...
10.
Gomez-Paz A, Drucker-Colin R, Milan-Aldaco D, Palomero-Rivero M, Ambriz-Tututi M
Neuroscience
. 2017 Sep;
387:123-134.
PMID: 28890053
The present study evaluates the possible antinociceptive effect of chromosphere transplants in rats injected with 6-hydroxydopamine (6-OHDA), a model of Parkinson's disease. Male adult Wistar rats received 40μg/0.5μl of 6-OHDA...